Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06074588
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 556
Large-scale testing (Phase 3)Study completedNCT00693992
What this trial is testing

Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

Who this might be right for
Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 210
Very early researchStudy completedNCT03158883
What this trial is testing

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)
Megan Daly, MD 8
Large-scale testing (Phase 3)Study completedNCT01085136
What this trial is testing

LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,154
Testing effectiveness (Phase 2)Ended earlyNCT00885963
What this trial is testing

Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Cyclacel Pharmaceuticals, Inc. 62
Testing effectiveness (Phase 2)Ended earlyNCT02117024
What this trial is testing

Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Heat Biologics 66
Early research (Phase 1)Study completedNCT02358473
What this trial is testing

Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Kyowa Kirin, Inc. 13
Early research (Phase 1)Study completedNCT00466466
What this trial is testing

Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

Who this might be right for
Small-Cell Lung Cancer
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT02666105
What this trial is testing

Exemestane in Post-Menopausal Women With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Ended earlyNCT05062980
What this trial is testing

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Genprex, Inc. 5
Large-scale testing (Phase 3)Study completedNCT04471428
What this trial is testing

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 366
Testing effectiveness (Phase 2)UnknownNCT05460481
What this trial is testing

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

Who this might be right for
Non Small Cell Lung Cancer
Hunan Cancer Hospital 29
Testing effectiveness (Phase 2)UnknownNCT03502850
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 507
Testing effectiveness (Phase 2)Study completedNCT01107444
What this trial is testing

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 180
Early research (Phase 1)Study completedNCT02592577
What this trial is testing

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerCarcinoma
Adaptimmune 28
Testing effectiveness (Phase 2)Study completedNCT00309907
What this trial is testing

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more
Children's Oncology Group 39
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Large-scale testing (Phase 3)Study completedNCT01828099
What this trial is testing

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 376
Testing effectiveness (Phase 2)Study completedNCT05807048
What this trial is testing

Daratumumab in STK11 Mutated NSCLC

Who this might be right for
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
NYU Langone Health 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158840
What this trial is testing

AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment

Who this might be right for
Non-Small Cell Lung Cancer
Akeso 60
Next Page